期刊文献+

瑞舒伐他汀钙对脑梗死患者动脉粥样硬化和脑血流动力学的影响 被引量:18

Effects of Rosuvastatin on atherosclerosis and cerebral hemodynamics in patients with acute cerebral infarction
下载PDF
导出
摘要 目的观察瑞舒伐他汀钙对脑梗死患者的动脉粥样硬化及脑血流动力学的影响。方法对68例脑梗死患者应用瑞舒伐他汀钙10 mg/d连续口服6个月,观察治疗前后颈内动脉粥样硬化程度、狭窄程度、不稳定斑块及双侧大脑中动脉的血流情况。结果经治疗6个月后,患者不稳定斑块检出率下降,颈内动脉粥样硬化程度、狭窄程度及双侧大脑中动脉的血流情况均较前改善,且治疗前后比较均有显著性差异(P均<0.05)。结论对于脑梗死患者,瑞舒伐他汀钙有稳定及逆转动脉斑块的作用,具有显著抗动脉粥样硬化和改善脑血流动力学的作用,可以在缺血性脑卒中临床二级预防中广泛应用。 Objective It is to observe the influence of Rosuvastatin on atherosclerosis and cerebral hemodynamics in patients with acute cerebral infarction.Methods 68 patients with acute cerebral infarction received Rosuvastatin treatment 10 mg every day for 6 months.The changes of carotid atherosclerosis,carotid artery stenosis,unstable plaque and cerebral hemodynamics were observed after treatment.Results After treatment for 6 months,the detectable rate of unstable plaques was lower,the degree of carotid atherosclerosis and carotid artery stenosis and the situation of cerebral hemodynamics were improved,there were significant differences compared with before treatment(P 0.05).Conclusion Rosuvastatin can make the plaque stable and reversal,has significant anti-artery atherosclerosis effect and improves cerebral hemodynamics in patients with cerebral infarction.So it can be used generally in the secondary prevention of cerebral ischemic stroke.
出处 《现代中西医结合杂志》 CAS 2013年第20期2178-2180,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 瑞舒伐他汀钙 脑梗死 动脉粥样硬化 Rosuvastatin cerebral infarction atherosclerosis
  • 相关文献

参考文献3

二级参考文献26

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33008
  • 2Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504. 被引量:1
  • 3LaRosa JC, Grundy SM, Waters DD, et al; Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425-1435. 被引量:1
  • 4Pedersen TR, Faergeman O, Kastelein J J, et al; Incremental Decrease in End Points Through Aggressive Lipid Lowedng (IDEAL) Study Group. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study:a randomized controlled trial. JAMA. 2005;294:2437-2445. 被引量:1
  • 5Grundy SM, Cleeman JI, Merz CN, et al; Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ Guidelines. J Am Coll Cardiol. 2004;44:720-732. 被引量:1
  • 6Blankenhom DH, Azen SP, Kramsch DM, et al;MARS Research Group. Coronary angiographic changes with Iovastatin therapy: the Monitored Atherosclerosis Regression Study (MARS). Ann Intern Med.1993;119:969-976. 被引量:1
  • 7Waters D, Higginson L, Gladstone P, et al. Effects of monotherapy with HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed be serial quantitaUve arteriography: the Canadian Coronary Atherosclerosis Intervention Trial(CCAIT). Circulation. 1994;89:959-968. 被引量:1
  • 8Jukema JW, Bruschke AV, van Boven A J, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels: the Regression Growth Evaluation Statin Study (REGRESS). Circulation. 1995;91:2528-2540. 被引量:1
  • 9Pitt B, Mancini GB, Ellis SG, Rosrnan HS, Park J-S,McGovem ME. Pravastatin limitaUon of atherosclerosis in the coronary arteries (PLAC Ⅰ): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol. 1995;26:1133-1139. 被引量:1
  • 10Brown G, Albers J J, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipidlowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990;323:1289-1298. 被引量:1

共引文献33362

同被引文献165

引证文献18

二级引证文献146

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部